You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
长江健康(002435.SZ):”奥美拉唑肠溶胶囊“拟中标全国药品集采
格隆汇 08-20 20:41

格隆汇 8 月 20日丨长江健康(002435.SZ)公布,2020年8月20日,长江润发健康产业股份有限公司(以下简称“公司”)旗下海南海灵化学制药有限公司(以下简称“海灵药业”)参加了国家组织药品集中采购和使用联合采购办公室(以下简称“联采办”)组织的第三批全国药品集中采购工作。海灵药业已获得国家药品监督管理局仿制药质量和疗效一致性评价的药品奥美拉唑肠溶胶囊(20mg/粒)拟中选本次集中采购。

本次集中采购是国家组织的第三批药品集中带量采购,采购周期中,医疗机构将优先使用本次药品集中采购中选药品,并确保完成约定采购量。本次公司产品拟中选价格具体以联采办公布的价格为准。若公司后续签订采购合同并实施后,将有利于进一步扩大相关产品的销售,提高市场占有率,促进公司相关产品国内市场的开拓,夯实公司在消化类药品领域的市场地位,对公司的未来经营业绩产生积极的影响。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account